Paul Hastings advises Keensight Capital on the LBO of Unither Pharmaceuticals
Paris – Paul Hastings (Europe) LLP advised Keensight Capital on the LBO of Unither Pharmaceuticals, structured, alongside the management team by a consortium composed of GIC, Keensight Capital, IK Partners and Parquest. The transaction is subject to approval by various regulatory authorities.
The Paul Hastings team was led by partners Olivier Deren and Sébastien Crepy, and included associate Vincent Nacinovic on the corporate and contractual aspects, and partners Olivier Vermeulen and Marc Zerah on the financing aspects.
More details about the transaction can be found here.
With widely recognized elite teams across 18 core practices, Paul Hastings is a premier law firm with a culture of excellence focused on providing intellectual capital and superior execution globally to the world's leading investment banks, asset managers and corporations.